Back To Search Results

Adie Syndrome

Editor: Kyle Blair Updated: 2/15/2026 2:34:55 PM

Introduction

Adie syndrome, also known as Holmes–Adie syndrome, is named after William John Adie, a British neurologist of Australian descent, and Sir Gordon Morgan Holmes, an Irish neurologist. Both independently reported the condition in 1931, with Adie naming it Pseudo-Argyll Robertson pupil.[1] Earlier, in 1881, Hughlings Jackson described mydriasis with pupillary paralysis. In 1906, Markus first characterized the tonic pupil. In 1914, Oloff demonstrated that tonic pupils could result from causes other than syphilis.

Adie syndrome is a relatively common neurological disorder of uncertain etiology, characterized by unilateral or bilateral tonic pupillary dilation with light–near dissociation and tendon areflexia. Symptoms arise from autonomic disturbances that affect vasomotor and sudomotor functions. The disorder demonstrates a female predominance and is associated with absent or reduced deep tendon reflexes (DTRs). Progressive miosis, bilateral involvement (approximately 4% per year), and continued loss of DTRs are frequently observed.[2] When associated with hypohidrosis, the condition defines the variant known as Ross syndrome.[3][4]

Etiology

Register For Free And Read The Full Article
Get the answers you need instantly with the StatPearls Clinical Decision Support tool. StatPearls spent the last decade developing the largest and most updated Point-of Care resource ever developed. Earn CME/CE by searching and reading articles.
  • Dropdown arrow Search engine and full access to all medical articles
  • Dropdown arrow 10 free questions in your specialty
  • Dropdown arrow Free CME/CE Activities
  • Dropdown arrow Free daily question in your email
  • Dropdown arrow Save favorite articles to your dashboard
  • Dropdown arrow Emails offering discounts

Learn more about a Subscription to StatPearls Point-of-Care

Etiology

Adie syndrome often has no identifiable cause. In rare cases, the condition may result from local disorders affecting the ciliary ganglion, including infections such as syphilis, varicella, human parvovirus B19, HIV, and Lyme disease.[5][6][7] Ischemic processes related to lymphomatoid granulomatosis, migraine, or giant cell arteritis have also been reported.[8][9] Autoimmune disorders associated with Adie syndrome include Sjögren syndrome, polyarteritis nodosa, sarcoidosis, systemic lupus erythematosus, amyloidosis, Guillain-Barré syndrome, and Vogt-Koyanagi-Harada disease.[10][11][12]

Cardiovascular disorders, exposure to local or general anesthesia, orbital or choroidal tumors, and orbital surgery for orbital floor fractures have been implicated as well.[13][14][15][16] Neuromuscular conditions, such as Lambert-Eaton myasthenic syndrome, and paraneoplastic syndromes associated with anti-Hu antibodies have also been documented.[17][18][19] Retinal photocoagulation may damage ciliary nerves within the suprachoroidal space, resulting in tonic pupil formation.[20][21] An association with familial dysautonomia has been described.[22]

Two cases of Adie syndrome associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection have recently been reported.[23][24] Proposed mechanisms include direct viral invasion of the ciliary nerves or ganglion due to neurotropism or a delayed immune-mediated response.[25]

Epidemiology

The incidence of Adie syndrome is approximately 4.7 per 100,000 people per year, with a prevalence of approximately 2 per 1000 individuals. Young adults, typically aged between 25 and 45 (mean age 32), are the most commonly affected population. A female predominance is observed, with a ratio of 2.6:1. Most cases are sporadic, while familial associations are rare.[26] The disorder is unilateral in approximately 80% of cases.

Pathophysiology

The pathophysiology of Adie syndrome involves damage to the ciliary ganglion, most often caused by an inflammatory process. Pupillary symptoms result from injury to the postganglionic parasympathetic fibers supplying the ciliary body and iris. These fibers originate as preganglionic fibers that travel along the oculomotor nerve to synapse at the ciliary ganglion within the orbit. Damage to the dorsal root ganglia of the spinal cord may also occur, resulting in impaired autonomic control throughout the body.

Parasympathetic axons for ciliary body accommodation are approximately 30 times more numerous than those for pupillary function. Following injury, fibers previously dedicated to ciliary body function are more likely to divert to the pupil, leading to aberrant regeneration. This process impairs the normal pupillary light response and produces light–near dissociation.[27] Activation of the near response elicits a tonic pupillary reaction, characterized by an abnormal and prolonged constriction resembling accommodation. Reinnervation and postsynaptic receptor upregulation after ciliary ganglion damage lead to denervation hypersensitivity, manifesting as exaggerated responses to cholinergic stimulation.

Patients with Adie syndrome show reduced neuronal counts in the thoracic and lumbar dorsal root ganglia and medial spinal cord, along with impaired axonal myelination. The condition may also present with a chronic cough due to involvement of afferent or efferent vagal pathways.[28]

Histopathology

Postmortem studies of patients with Adie syndrome demonstrate degeneration of the ciliary ganglion on the affected side, accompanied by partial atrophy of the sphincter pupillae muscle. Minimal neuronal degeneration has also been observed in the superior cervical ganglion, sacral dorsal root ganglion, and sciatic nerve.[29] No underlying cause for these abnormalities has been identified in the studied cases.

History and Physical

Adie syndrome typically presents with at least one mydriatic pupil exhibiting poor or absent pupillary light reaction, a tonic pupillary near response with light–near dissociation, and decreased or absent DTRs. The disorder is additionally associated with sudomotor abnormalities in Ross syndrome. The Achilles tendon reflex is most commonly affected. Patients may report difficulty reading and photophobia. Additional findings may include increased manifest hyperopia, anisometropia, segmental sphincter palsy, cholinergic supersensitivity of denervated muscles, and cardiovascular abnormalities such as orthostatic hypotension.[30] Adie syndrome may also be associated with chronic coughing.[31] Signs and symptoms of comorbid conditions, such as infections, autoimmune disorders, or malignancy, may also be observed.

Evaluation

Examination

The hallmark of the Adie pupil is a strong, tonic response to near stimulation with slow and sustained relaxation, resulting from aberrant regeneration of the iris sphincter and hypersensitivity to muscarinic receptor agonists (eg, pilocarpine). Over time, the tonic pupil, typically larger than the uninvolved fellow eye, may decrease in size, a condition referred to as the “little old Adie” pupil. The little old Adie pupil is characterized by poor light reaction and preserved tonic near response. Approximately 20% of patients with Adie pupils demonstrate bilateral involvement, with an annual incidence of 4%. Anisocoria greater than 1 mm and the presence of sectoral palsy on slit-lamp examination aid in differentiating Adie syndrome from mydriasis caused by generalized neuropathy.[32]

Pharmacologic Testing

Adie syndrome is primarily a clinical diagnosis. Low-concentration pilocarpine (0.125%–0.1%) may be used to demonstrate cholinergic denervation supersensitivity, which is present in approximately 80% of tonic pupils.[33] Following administration, the affected pupil exhibits a greater miotic response than the normal fellow eye; thus, these low concentrations are typically ineffective in normal pupils. However, some pupils with third nerve palsy also respond to 0.1% pilocarpine. Therefore, pharmacologic testing alone is insufficient for definitive diagnosis of an Adie pupil.[34]

Sweat Testing

Additional assessments that can help rule out Ross or Harlequin syndrome include the starch–iodine and spoon tests. Both evaluations aid in detecting anhidrosis.[35][36]

Etiologic Evaluation

Conditions that may mimic or contribute to Adie syndrome, including systemic dysautonomia, syphilis, diabetes, chronic alcoholism, encephalitis, multiple sclerosis, peripheral neuropathies (eg, Charcot–Marie–Tooth disease), rare midbrain tumors, herpes zoster, and neurosarcoidosis, should be considered and excluded. Specific workup should be tailored based on the patient's other clinical manifestations. Computed tomography and magnetic resonance imaging may aid in the evaluation of focal hypoactive reflexes.

Treatment / Management

Most patients with idiopathic Adie syndrome do not require treatment. Management of underlying systemic causes should focus on addressing any underlying systemic causes and associated autonomic neuropathies. Accommodative paresis may be corrected with reading glasses. Topical low-dose pilocarpine or physostigmine drops may be administered for both diagnostic and therapeutic purposes. Thoracic sympathectomy is the preferred intervention for diaphoresis in patients who fail to respond to conservative pharmacologic management.[37](B3)

Differential Diagnosis

The differential diagnoses of Adie syndrome include other causes of light–near dissociation, such as Argyll Robertson pupil, which occurs in late-stage syphilis and is associated with miosis.[38] Other etiologies of mydriasis should be excluded, including pharmacologic dilation, which lacks light–near dissociation; oculomotor nerve palsy, which may be accompanied by ophthalmoplegia and ptosis; and optic nerve diseases, which present with a relative afferent pupillary defect and diminished vision.[39]

Systemic autonomic neuropathies, such as Ross and Harlequin syndromes, may also affect the ciliary ganglion and produce a tonic pupil.[40] Ross syndrome is characterized by the triad of tonic pupil, hyporeflexia, and segmental anhidrosis.[41][42] Harlequin syndrome is a rare sympathetic disorder characterized by unilateral decreased or absent flushing and sweating, with exaggerated responses on the contralateral normal side, particularly in the face, neck, arm, and chest, in response to heat, exercise, or emotional stimuli.[43][44] Some patients (13% in a series) also exhibit a tonic pupil, although Horner syndrome is more common and may coexist with a tonic pupil.[45]

A "little old Adie" pupil with miosis should be distinguished from other causes of constricted pupils. Horner syndrome, for example, presents with a miotic pupil, usually accompanied by ptosis and apparent enophthalmos.[46] Miosis may also appear as an early sign of temporal lobe herniation following head injury due to oculomotor nerve irritation (Hutchison stage I), although this finding is typically followed by pupillary dilatation.[47]

Prognosis

Adie syndrome usually follows a nonprogressive course. The condition is not life-threatening and does not cause disability or affect mortality. Loss of DTRs is permanent and may progress gradually. Most patients require only reassurance after the diagnosis is confirmed. Rare associations of an Adie pupil with angle-closure glaucoma have been reported in individuals.[48] Accommodative paresis typically improves spontaneously over time. The pupillary light reaction weakens progressively, accompanied by increasing light–near dissociation. The pupil may gradually decrease in size, resulting in the "little old Adie" pupil.

Complications

Adie syndrome may rarely result in angle-closure glaucoma, leading to episodes of blurred vision and ocular pain.[49] Management involves medical therapy to lower intraocular pressure and laser iridotomy to prevent pupillary block. 

Adie syndrome has also been reported to cause amblyopia in children, resulting from the conversion of latent hypermetropia to manifest hypermetropia secondary to accommodative paresis.[50] Correction of the refractive error, combined with occlusion therapy, has been shown to be effective in managing this complication.

Deterrence and Patient Education

Patients should be reassured regarding the typically benign nature of Adie syndrome. Individuals at risk for angle-closure glaucoma should be informed of its potential development and educated about associated symptoms and precipitating factors. Parents of children with Adie syndrome should be counseled on the importance of ongoing follow-up to monitor for refractive errors and anisometropia, which can lead to amblyopia if not appropriately managed.

Enhancing Healthcare Team Outcomes

Care coordination by an interprofessional healthcare team, including neurologists and ophthalmologists, facilitates earlier detection and optimizes patient care. Early involvement of infectious disease and rheumatology specialists in patients presenting with tonic pupils can reduce time to diagnosis and help exclude alternative causes. In cases with cardiovascular involvement, select patients may necessitate consultation with a cardiology team. Pediatric care is particularly important for preventing or managing amblyopia. Most evidence guiding the management of Adie syndrome is derived from case series and expert opinion.

References


[1]

Adie WJ. PSEUDO-ARGYLL ROBERTSON PUPILS WITH ABSENT TENDON REFLEXES: A BENIGN DISORDER SIMULATING TABES DORSALIS. British medical journal. 1931 May 30:1(3673):928-30     [PubMed PMID: 20776197]


[2]

Thompson HS. Adie's syndrome: some new observations. Transactions of the American Ophthalmological Society. 1977:75():587-626     [PubMed PMID: 613531]


[3]

ROSS AT. Progressive selective sudomotor denervation; a case with coexisting Adie's syndrome. Neurology. 1958 Nov:8(11):809-17     [PubMed PMID: 13590391]

Level 3 (low-level) evidence

[4]

Weller M, Wilhelm H, Sommer N, Dichgans J, Wiethölter H. Tonic pupil, areflexia, and segmental anhidrosis: two additional cases of Ross syndrome and review of the literature. Journal of neurology. 1992 Apr:239(4):231-4     [PubMed PMID: 1597691]

Level 3 (low-level) evidence

[5]

Sakai T, Shikishima K, Mizobuchi T, Yoshida M, Kitahara K. Bilateral tonic pupils associated with neurosyphilis. Japanese journal of ophthalmology. 2003 Jul-Aug:47(4):368-71     [PubMed PMID: 12842205]

Level 3 (low-level) evidence

[6]

Stricker RB, Winger EE. Holmes-Adie syndrome and Lyme disease. Lancet (London, England). 2001 Mar 10:357(9258):805     [PubMed PMID: 11254002]

Level 3 (low-level) evidence

[7]

Cerny R, Rozsypal H, Kozner P, Machala L. Bilateral Holmes-Adie syndrome as an early manifestation of the HIV neuropathy. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 2010 Oct:31(5):661-3. doi: 10.1007/s10072-010-0355-9. Epub 2010 Jun 22     [PubMed PMID: 20567990]

Level 3 (low-level) evidence

[8]

Foroozan R, Buono LM, Savino PJ, Sergott RC. Tonic pupils from giant cell arteritis. The British journal of ophthalmology. 2003 Apr:87(4):510-2     [PubMed PMID: 12642330]

Level 3 (low-level) evidence

[9]

Purvin VA. Adie's tonic pupil secondary to migraine. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society. 1995 Mar:15(1):43-4     [PubMed PMID: 7780572]

Level 3 (low-level) evidence

[10]

Bennett JL, Pelak VA, Mourelatos Z, Bird S, Galetta SL. Acute sensorimotor polyneuropathy with tonic pupils and an abduction deficit: an unusual presentation of polyarteritis nodosa. Survey of ophthalmology. 1999 Jan-Feb:43(4):341-4     [PubMed PMID: 10025516]

Level 3 (low-level) evidence

[11]

Garza Leon M, Herrera-Jimenez IP, González-Madrigal PM. Complete Vogt-Koyanagi-Harada disease and Holmes-Adie syndrome: case report. Ocular immunology and inflammation. 2014 Aug:22(4):336-40. doi: 10.3109/09273948.2013.848906. Epub 2013 Nov 11     [PubMed PMID: 24215593]

Level 3 (low-level) evidence

[12]

Pueyo-Asensio C, Saint Gerons Trecu M, Rubio Pérez MA, Matheu Fabra A. Holmes-Adie syndrome as an early manifestation of systemic lupus erythematosus. Archivos de la Sociedad Espanola de Oftalmologia. 2021 Mar:96(3):167-170. doi: 10.1016/j.oftal.2020.03.012. Epub 2020 Jul 15     [PubMed PMID: 32680767]


[13]

Guaraldi P, Mathias CJ. Progression of cardiovascular autonomic dysfunction in Holmes-Adie syndrome. Journal of neurology, neurosurgery, and psychiatry. 2011 Sep:82(9):1046-9. doi: 10.1136/jnnp.2009.195917. Epub 2010 Jun 18     [PubMed PMID: 20562402]

Level 3 (low-level) evidence

[14]

Kobayashi M, Takenami T, Kimotsuki H, Mukuno K, Hoka S. Adie syndrome associated with general anesthesia. Canadian journal of anaesthesia = Journal canadien d'anesthesie. 2008 Feb:55(2):130-1. doi: 10.1007/BF03016329. Epub     [PubMed PMID: 18245077]

Level 3 (low-level) evidence

[15]

Goldstein SM, Liu GT, Edmond JC, Katowitz JA, Rorke LB. Orbital neural-glial hamartoma associated with a congenital tonic pupil. Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus. 2002 Feb:6(1):54-5     [PubMed PMID: 11907481]

Level 3 (low-level) evidence

[16]

Stromberg BV, Knibbe M. Anisocoria following reduction of bilateral orbital floor fractures. Annals of plastic surgery. 1988 Nov:21(5):486-8     [PubMed PMID: 3232939]

Level 3 (low-level) evidence

[17]

Bruno MK, Winterkorn JM, Edgar MA, Kamal A, Stübgen JP. Unilateral Adie pupil as sole ophthalmic sign of anti-Hu paraneoplastic syndrome. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society. 2000 Dec:20(4):248-9     [PubMed PMID: 11130750]

Level 3 (low-level) evidence

[18]

Wirtz PW, de Keizer RJ, de Visser M, Wintzen AR, Verschuuren JJ. Tonic pupils in Lambert-Eaton myasthenic syndrome. Muscle & nerve. 2001 Mar:24(3):444-5     [PubMed PMID: 11353435]

Level 3 (low-level) evidence

[19]

Zhang L, Luo S, Jin H, Lv X, Chen J. Anti-Hu Antibody-Associated Adie's Pupil and Paraneoplastic Sensorimotor Polyneuropathy Caused by Primary Mediastinal Small Cell Carcinoma. Frontiers in neurology. 2019:10():1236. doi: 10.3389/fneur.2019.01236. Epub 2019 Nov 26     [PubMed PMID: 31849812]


[20]

Patel JI, Jenkins L, Benjamin L, Webber S. Dilated pupils and loss of accommodation following diode panretinal photocoagulation with sub-tenon local anaesthetic in four cases. Eye (London, England). 2002 Sep:16(5):628-32     [PubMed PMID: 12194080]

Level 3 (low-level) evidence

[21]

Wilhelm H. Neuro-ophthalmology of pupillary function--practical guidelines. Journal of neurology. 1998 Sep:245(9):573-83     [PubMed PMID: 9758294]


[22]

Goldberg MF, Payne JW, Brunt PW. Ophthalmologic studies of familial dysautonomia. The Riley-Day syndrome. Archives of ophthalmology (Chicago, Ill. : 1960). 1968 Dec:80(6):732-43     [PubMed PMID: 4881323]


[23]

Ortiz-Seller A, Martínez Costa L, Hernández-Pons A, Valls Pascual E, Solves Alemany A, Albert-Fort M. Ophthalmic and Neuro-ophthalmic Manifestations of Coronavirus Disease 2019 (COVID-19). Ocular immunology and inflammation. 2020 Nov 16:28(8):1285-1289. doi: 10.1080/09273948.2020.1817497. Epub 2020 Oct 6     [PubMed PMID: 33021422]


[24]

Ordás CM, Villacieros-Álvarez J, Pastor-Vivas AI, Corrales-Benítez Á. Concurrent tonic pupil and trochlear nerve palsy in COVID-19. Journal of neurovirology. 2020 Dec:26(6):970-972. doi: 10.1007/s13365-020-00909-1. Epub 2020 Sep 10     [PubMed PMID: 32910433]


[25]

Çakır GY, PaÅŸaoÄŸlu IB, Çakır İ, Solmaz B. Adie's tonic pupil after COVID-19: a case report and literature review. Romanian journal of ophthalmology. 2024 Apr-Jun:68(2):89-91. doi: 10.22336/rjo.2024.18. Epub     [PubMed PMID: 39006340]

Level 3 (low-level) evidence

[26]

Rudolf Gde M. Tonic Pupils with Absent Tendon Reflexes in Mother and Daughter. The Journal of neurology and psychopathology. 1936 Apr:16(64):367-8     [PubMed PMID: 21610838]


[27]

Kardon RH, Corbett JJ, Thompson HS. Segmental denervation and reinnervation of the iris sphincter as shown by infrared videographic transillumination. Ophthalmology. 1998 Feb:105(2):313-21     [PubMed PMID: 9479293]


[28]

Kimber J, Mitchell D, Mathias CJ. Chronic cough in the Holmes-Adie syndrome: association in five cases with autonomic dysfunction. Journal of neurology, neurosurgery, and psychiatry. 1998 Oct:65(4):583-6     [PubMed PMID: 9771793]

Level 3 (low-level) evidence

[29]

Agbeja AM, Dutton GN. Adie's syndrome as a cause of amblyopia. Journal of pediatric ophthalmology and strabismus. 1987 Jul-Aug:24(4):176-7     [PubMed PMID: 3668764]

Level 3 (low-level) evidence

[30]

Emond D, Lebel M. Orthostatic hypotension and Holmes-Adie syndrome. Usefulness of the Valsalva ratio in the evaluation of baroreceptor dysfunction. Journal of human hypertension. 2002 Sep:16(9):661-2     [PubMed PMID: 12214264]

Level 3 (low-level) evidence

[31]

Ford PA, Barnes PJ, Usmani OS. Chronic cough and Holmes-Adie syndrome. Lancet (London, England). 2007 Jan 27:369(9558):342     [PubMed PMID: 17258674]

Level 3 (low-level) evidence

[32]

Vimisha MN, Virna MS, Karthik K, Sharanya R. Adie's pupil and systemic manifestations: a rare unilateral presentation. GMS ophthalmology cases. 2024:14():Doc14. doi: 10.3205/oc000246. Epub 2024 Dec 3     [PubMed PMID: 39811490]

Level 3 (low-level) evidence

[33]

Leavitt JA, Wayman LL, Hodge DO, Brubaker RF. Pupillary response to four concentrations of pilocarpine in normal subjects: application to testing for Adie tonic pupil. American journal of ophthalmology. 2002 Mar:133(3):333-6     [PubMed PMID: 11860969]

Level 1 (high-level) evidence

[34]

Jacobson DM. Pupillary responses to dilute pilocarpine in preganglionic 3rd nerve disorders. Neurology. 1990 May:40(5):804-8     [PubMed PMID: 2330108]


[35]

Ballestero-Díez M, García-Río I, Daudén E, Corrales-Arroyo M, García-Díez A. Ross syndrome, an entity included within the spectrum of partial disautonomic syndromes. Journal of the European Academy of Dermatology and Venereology : JEADV. 2005 Nov:19(6):729-31     [PubMed PMID: 16268880]

Level 3 (low-level) evidence

[36]

Cheshire WP Jr, Goldstein DS. The physical examination as a window into autonomic disorders. Clinical autonomic research : official journal of the Clinical Autonomic Research Society. 2018 Feb:28(1):23-33. doi: 10.1007/s10286-017-0494-7. Epub 2018 Jan 2     [PubMed PMID: 29294184]


[37]

Serra Mitjans M, Callejas Pérez MA, Valls Solé J, Grimalt Santacana R, Rubio Garay M, Iglesias Sentís M. [Surgical treatment for compensatory hyperhidrosis in Adie syndrome]. Archivos de bronconeumologia. 2004 Feb:40(2):97-9     [PubMed PMID: 14746734]

Level 3 (low-level) evidence

[38]

Thompson HS, Kardon RH. The Argyll Robertson pupil. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society. 2006 Jun:26(2):134-8     [PubMed PMID: 16845316]


[39]

Xu SY, Song MM, Li L, Li CX. Adie's Pupil: A Diagnostic Challenge for the Physician. Medical science monitor : international medical journal of experimental and clinical research. 2022 Mar 8:28():e934657. doi: 10.12659/MSM.934657. Epub 2022 Mar 8     [PubMed PMID: 35304432]


[40]

Shin RK, Galetta SL, Ting TY, Armstrong K, Bird SJ. Ross syndrome plus: beyond horner, Holmes-Adie, and harlequin. Neurology. 2000 Dec 26:55(12):1841-6     [PubMed PMID: 11134383]

Level 3 (low-level) evidence

[41]

Wolfe GI, Galetta SL, Teener JW, Katz JS, Bird SJ. Site of autonomic dysfunction in a patient with Ross' syndrome and postganglionic Horner's syndrome. Neurology. 1995 Nov:45(11):2094-6     [PubMed PMID: 7501165]

Level 3 (low-level) evidence

[42]

Assaf A, Khaddour S, Borghol W, Karaja S, Alfaksh F, Al-Shami K. Ross syndrome following COVID-19 infection in an 18-year-old Syrian male patient: a case report. Journal of medical case reports. 2025 Sep 30:19(1):474. doi: 10.1186/s13256-025-05483-w. Epub 2025 Sep 30     [PubMed PMID: 41029707]

Level 3 (low-level) evidence

[43]

Guilloton L, Demarquay G, Quesnel L, De Charry F, Drouet A, Zagnoli F. [Dysautonomic syndrome of the face with Harlequin sign and syndrome: Three new cases and a review of the literature]. Revue neurologique. 2013 Nov:169(11):884-91. doi: 10.1016/j.neurol.2013.01.628. Epub 2013 May 29     [PubMed PMID: 23726525]

Level 3 (low-level) evidence

[44]

Kaur S, Aggarwal P, Jindal N, Dayal S, Jairath V, Jain VK, Virdi S. Harlequin syndrome: a mask of rare dysautonomic syndromes. Dermatology online journal. 2015 Apr 16:21(4):. pii: 13030/qt3q39d7mz. Epub 2015 Apr 16     [PubMed PMID: 25933078]


[45]

Bremner F, Smith S. Pupillographic findings in 39 consecutive cases of harlequin syndrome. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society. 2008 Sep:28(3):171-7. doi: 10.1097/WNO.0b013e318183c885. Epub     [PubMed PMID: 18769278]

Level 2 (mid-level) evidence

[46]

Martin TJ. Horner Syndrome: A Clinical Review. ACS chemical neuroscience. 2018 Feb 21:9(2):177-186. doi: 10.1021/acschemneuro.7b00405. Epub 2017 Dec 20     [PubMed PMID: 29260849]


[47]

Kulkarni AR, Aggarwal SP, Kulkarni RR, Deshpande MD, Walimbe PB, Labhsetwar AS. Ocular manifestations of head injury: a clinical study. Eye (London, England). 2005 Dec:19(12):1257-63     [PubMed PMID: 15543173]


[48]

Kawana K, Okamoto F, Nose H, Oshika T. A case of angle closure glaucoma caused by plateau iris and adie's pupil. American journal of ophthalmology. 2003 May:135(5):717-8     [PubMed PMID: 12719087]

Level 3 (low-level) evidence

[49]

Leibovitch I, Kurtz S, Almog Y. Adie's tonic pupil-induced angle-closure glaucoma. Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde. 2002 Jan-Feb:216(1):71-2     [PubMed PMID: 11901294]

Level 3 (low-level) evidence

[50]

Firth AY. Adie syndrome: evidence for refractive error and accomodative asymmetry as the cause of amblyopia. American journal of ophthalmology. 1999 Jul:128(1):118-9     [PubMed PMID: 10482113]

Level 3 (low-level) evidence